ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 935,41
-0,62%
Dow Jones
37 903,29
0,00%
DAX
17 946,44
0,14%
Brent Oil
84,20
0,79%
Bitcoin
58 520,59
0,49%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. Biosyent Inc (RX)

  7. Biosyent Inc (RX) Actualités

RX

Biosyent (RX)

Biosyent Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:RX
DateHeureSourceTitreSymboleSociété
24/08/202302h22PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:RXBiosyent Inc
16/03/202112h01PR Newswire (Canada)Combogesic® - First Acetaminophen + Ibuprofen Combination Tablet - Now Available for Canadians with Acute PainTSXV:RXBiosyent Inc
16/03/202112h01PR Newswire (Canada)Combogesic(MD) - le premier comprimé associant l'acétaminophène et l'ibuprofène - maintenant disponible pour les Canadien...TSXV:RXBiosyent Inc
25/05/201619h02PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - RXTSXV:RXBiosyent Inc
25/05/201619h00PR Newswire (Canada)IIROC Trading Resumption - RXTSXV:RXBiosyent Inc
25/05/201618h46PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - RXTSXV:RXBiosyent Inc
25/05/201618h44PR Newswire (Canada)IIROC Trading Halt - RXTSXV:RXBiosyent Inc
23/07/201415h43Marketwired CanadaBioSyent Pharma Signs Exclusive Licensing and Distribution Agreement For New Urgent Care Drug ProductTSXV:RXBiosyent Inc
11/07/201423h15PR Newswire (Canada)S&P Dow Jones Indices Announces Quarterly Review of S&P/TSX Venture Select IndexTSXV:RXBiosyent Inc
11/07/201423h15PR Newswire (Canada)Indices S&P Dow Jones annonce les résultats de l'analyse trimestrielle de l'indice sélect S&P/TSX de croissanceTSXV:RXBiosyent Inc
13/06/201423h12MarketwiredBioSyent to Present at the 2014 Bloom Burton & Co. Healthcare Investor ConferenceTSXV:RXBiosyent Inc
12/06/201422h01MarketwiredBioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 year Revenue Growth Rate of 608%TSXV:RXBiosyent Inc
12/06/201414h00MarketwiredBioSyent Pharma Receives Health Canada Approval to Market New Urgent Care ProductTSXV:RXBiosyent Inc
06/06/201414h16MarketwiredBioSyent Annual General Meeting of Shareholders - June 10, 2014TSXV:RXBiosyent Inc
23/05/201414h00MarketwiredBioSyent to Present at the 2014 Marcum MicroCap Investor ConferenceTSXV:RXBiosyent Inc
21/05/201414h00MarketwiredBioSyent Pharma Launches New RepaGyn® Hormone-Free Vaginal SuppositoriesTSXV:RXBiosyent Inc
16/05/201414h00MarketwiredBioSyent Releases First Quarter 2014 Results-Sales Increase 59%, Net Income After Tax Up 49%TSXV:RXBiosyent Inc
12/03/201413h00Marketwired CanadaBioSyent Releases Q4 and Full Year 2013 Results: Full Year Sales Increase 55%, Net Income Up 25%, 3 Year CAGR 67%, Q4 Sales I...TSXV:RXBiosyent Inc
12/03/201413h00MarketwiredBioSyent Releases Q4 & Full Year 2013 Results: Full Year Sales Increase 55%, Net Income Up 25%, 3 Year CAGR 67%, Q4 Sales Inc...TSXV:RXBiosyent Inc
04/03/201414h00MarketwiredBioSyent Pharma Signs Exclusive Licence & Distribution Agreement for a New Gastrointestinal Health Product Already Approved b...TSXV:RXBiosyent Inc
04/03/201413h00Marketwired CanadaBioSyent Pharma Signs Exclusive Licence and Distribution Agreement for a New Gastrointestinal Health Product Already Approved...TSXV:RXBiosyent Inc
13/02/201414h00MarketwiredBioSyent Named to the 2014 TSX Venture Top 50(R) Ranking-Only TSX Venture Company to Be Recognized as a Top Performer for the...TSXV:RXBiosyent Inc
16/01/201414h00MarketwiredBioSyent Announces Appointment of New DirectorTSXV:RXBiosyent Inc
02/12/201314h00MarketwiredBioSyent to Present at the LD Micro VI Investor ConferenceTSXV:RXBiosyent Inc
21/11/201311h00Marketwired CanadaBioSyent Releases Q3 and Nine Month Results-Nine Month Sales Increase 53% and Profit Before Tax Up 77%TSXV:RXBiosyent Inc
01/10/201314h00Marketwired CanadaBioSyent Pharma Signs Exclusive Licence and Distribution Agreement for a New Women's Health Product Already Approved by Healt...TSXV:RXBiosyent Inc
22/08/201314h00Marketwired CanadaBioSyent Releases Q2 and Six Month Results: Six Month Sales Increase 57% and Profit Before Tax Up 68%TSXV:RXBiosyent Inc
06/06/201314h00Marketwired CanadaBioSyent Pharma Launches New FeraMAX(R) Powder-Water Soluble Polysaccharide-Iron Complex Iron SupplementTSXV:RXBiosyent Inc
04/06/201314h00Marketwired CanadaBioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 Year Revenue Growth Rate of 355%TSXV:RXBiosyent Inc
23/05/201314h00Marketwired CanadaBioSyent Pharma Submits Two New Drugs to Health Canada for Marketing ApprovalTSXV:RXBiosyent Inc
 Showing the most relevant articles for your search:TSXV:RX

Dernières Valeurs Consultées

NASDAQ
MSFT
Microsoft
EU
HO
Thales
EU
SGO
Cie de SaintGobain
NYSE
KO
Coca Cola
NYSE
NKE
Nike
EU
BNP
BNP Paribas
FTSE
UKX
FTSE 100
EU
LR
Legrand
EU
VIV
Vivendi
EU
RI
Pernod Ricard
EU
ORA
Orange
NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
EU
EN
Bouygues
EU
ML
Michelin
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés